drugset / Trial / NCT05629598
A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia .
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to explore the optimal dose and administration of the experimental drug, and to evaluate the safety and efficacy of the drug in patients with renal anemia. Patients with renal anemia on regular dialysis treatment are expected to be enrolled in this study.
Timeline
- Start
- 2022-04-13
- Primary completion
- 2023-03-17
- Completion
- 2023-08-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Human erythropoietin | Protein / enzyme biologic | — | — |
| Subject | PEG-EPO | Protein / enzyme biologic | — | — |